Controversy: Atrial fibrillation ablation should be performed in patients with HFpEF
Abstract
Abstract The role of atrial fibrillation (AF) ablation in the management of heart failure with preserved ejection fraction (HFpEF) remains an under investigated issue with no robust clinical trials data. This controversy reviews the evidence for and against AF ablation in this complex condition from two different perspectives reviewing mechanistic and observational evidence aswell as proposing future directions for research in the field.
// Source
Authors: Luigi Di Biase, Carolyn S.P. Lam, Fengwei Zou, Matthew M Y Lee, Pier David Lambiase
Institutions: Montefiore Medical Center, University College London, National University of Singapore, University of Glasgow, Duke-NUS Medical School, National Heart Centre Singapore, Baim Institute for Clinical Research, British Heart Foundation